Suicide remains a major global public health concern and a central focus of contemporary psychiatric practice. Within the United Nations Sustainable Development Goals, indicator 3.4.2 is used as the principal measure of progress in mental health and is operationalised through reductions in suicide mortality. The World Health Organization has aligned this indicator with a target of reducing suicide deaths by one-third by 2030. 1 Although this framework provides a clear and measurable objective, recent global trends raise concerns regarding whether current trajectories are sufficient to meet this target.
Globally, more than 720 000 people die by suicide each year, accounting for approximately 1.1% of all deaths. 1 The burden is unevenly distributed, with nearly three-quarters of deaths occurring in low- and middle-income countries, where mental health systems are often under-resourced. Between 2019 and 2021, the global age-standardised suicide mortality rate declined from 9.0 to 8.9 per 100 000. Although this represents a modest improvement, it is insufficient to place the global community on a trajectory consistent with the 2030 target. This pattern suggests that progress at a population level remains limited relative to the scale of the reduction required. 2
A central limitation of indicator 3.4.2 is its reliance on suicide mortality as a singular outcome measure. In psychiatric practice, suicide is not a discrete condition but a distal outcome arising from several interacting clinical and social processes, including affective disorders, substance misuse, trauma exposure and social isolation. Mortality therefore represents the end-point of a complex trajectory rather than being a direct reflection of system performance. However, global monitoring frameworks primarily evaluate progress using this distal outcome, without systematically incorporating indicators that capture how psychiatric systems function in practice.
From clinical and systems perspectives, proximal indicators are more informative for understanding whether individuals at risk are identified and supported effectively. These indicators include access to mental health services, availability of trained personnel, continuity of care following discharge and patterns of emergency presentations for self-harm. Such measures reflect the operational capacity of psychiatric systems and provide earlier signals of system strain. By contrast, mortality-based indicators may remain stable despite underlying deterioration in service provision, only changing once failures accumulate to the point of adverse outcomes.
Constraints in psychiatric system capacity remain a critical barrier to reducing suicide mortality. Mental health expenditure accounts for approximately 2.1% of total global health spending, despite mental disorders contributing an estimated 15% of years lived with disability. 3 Workforce shortages are also substantial. More than half the global population lives in countries with fewer than one psychiatrist per 100 000 people, and in many low- and middle-income countries the ratio is considerably lower. 3 These limitations extend across multidisciplinary teams, including psychologists, psychiatric nurses and community-based providers. Such shortages affect the ability of systems to deliver timely assessments, initiate treatment and maintain follow-up, all of which are essential components of suicide prevention. 4
System-level vulnerabilities are particularly evident during high-risk transitions in care. The period immediately following discharge from psychiatric in-patient services is associated with a markedly elevated risk of suicide, estimated to be 30 to 60 times higher than that of the general population. Reference Chung, Ryan, Hadzi-Pavlovic, Singh, Stanton and Large5 Despite this well-established risk, continuity of care during this period is frequently inconsistent. Limitations in staffing and service coordination may delay follow-up or reduce the intensity of post-discharge support. A mortality-based indicator alone cannot capture whether these critical transitions are managed effectively, nor can it identify gaps in continuity that may increase risk before fatal outcomes occur.
The interpretation of suicide mortality is further complicated by limitations with respect to data quality and reporting. Reliable estimates depend on comprehensive civil registration and vital statistics systems, which remain incomplete in several high-burden settings. 2 In addition, stigma, legal considerations and cultural factors may contribute to underreporting in some contexts. Global monitoring frameworks also rarely incorporate data on suicide attempts or non-fatal self-harm presentations. These events are clinically significant, as they represent both markers of population distress and opportunities for intervention. Their absence from routine monitoring limits our ability to detect emerging risks and respond proactively. Reference Werdin and Wyss6
Taken together, these considerations suggest that indicator 3.4.2 functions primarily as a lagging indicator of psychiatric system performance. Although it provides a clear measure of outcomes, it offers limited insight into the structural and operational conditions required to prevent suicide. If the 2030 targets are to be approached in a meaningful way, suicide mortality should be interpreted alongside complementary indicators that capture system capacity and responsiveness. Reference Hu7 These include workforce density, access to care, continuity following discharge and rates of self-harm presentations. Incorporating such measures into monitoring frameworks may provide earlier and more actionable information for policy makers and clinicians and may better align global targets with the realities of psychiatric service delivery.
Author contributions
S.A. formulated the idea for the letter, conducted the literature searches, synthesised the data and wrote the initial draft of the manuscript. M.V. and M.P.V. synthesised the literature and reviewed and revised the manuscript for clinical and structural accuracy. All authors reviewed and approved the final version of the manuscript for submission.
Funding
This study received no specific grant from any funding agency, commercial or not-for-profit sectors.
Declaration of interest
None.
eLetters
No eLetters have been published for this article.